Societe Generale’s Boston Scientific BSX Stock Holding History

Societe Generale’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$2.06M	Buy	+88,206	New	+$1.91M	0.01%	829

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Societe Generale's BSX Position: Q2 2016 in Review

Societe Generale opened a new position in Boston Scientific (BSX) in Q2 2016: 88,206 shares worth $2.06M. The stake represents 0.01% of the portfolio and ranks #829 among its holdings.

543 funds tracked by Wall St. Rank hold BSX as of Q2 2016.

Societe Generale held 88,206 shares of Boston Scientific worth $2.06M as of Q2 2016.
Boston Scientific was a new Societe Generale position in Q2 2016.
Boston Scientific made up 0.01% of Societe Generale's portfolio in Q2 2016, its #829 holding.
543 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.